AI-Assisted Echocardiography Trial Targets Rheumatic Heart Disease Screening in Uganda — Implications for Global Health Programs

References

1. 1.Children's Hospital Medical Center, Cincinnati. (2024). Artificial Intelligence to Scale Early Rheumatic Heart Disease Detection. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07599956
2. 2.Beaton, A., Okello, E., Lwabi, P., Mondo, C., McCarter, R., & Sable, C. (2012). Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation, 125(25), 3127-3132. https://doi.org/10.1161/CIRCULATIONAHA.112.096644
3. 3.Watkins, D. A., Johnson, C. O., Colquhoun, S. M., Karthikeyan, G., Beaton, A., Bukhman, G., ... & Roth, G. A. (2017). Global, regional, and national burden of rheumatic heart disease, 1990–2015. New England Journal of Medicine, 377(8), 713-722. https://doi.org/10.1056/NEJMoa1603693
4. 4.Zühlke, L., Engel, M. E., Karthikeyan, G., Rangarajan, S., Mackie, P., Cupido, B., ... & Mayosi, B. M. (2016). Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry. European Heart Journal, 37(13), 1115-1122. https://doi.org/10.1093/eurheartj/ehv711
5. 5.Nascimento, B. R., Beaton, A. Z., Nunes, M. C. P., Diamantino, A. C., Carmo, G. A. L., Oliveira, K. K. B., ... & Ribeiro, A. L. P. (2020). Echocardiographic prevalence of rheumatic heart disease in Brazilian schoolchildren: data from the PROVAR study. International Journal of Cardiology, 299, 78-84. https://doi.org/10.1016/j.ijcard.2019.10.007